Closing Market Recap — Monday, August 3, 2026
Closing Market Recap for Monday, August 3, 2026. How the day closed: indexes, leaders, laggards, and volatility.
Closing Market Recap for Monday, August 3, 2026. How the day closed: indexes, leaders, laggards, and volatility.
Palantir’s commercial growth and raised outlook clear the bull-case tests in the July 30 review, while valuation remains the next question.
ASML’s Q2 revenue rose 11% and new-system shipments rose 28%, but missing net bookings and weak price structure leave the cycle unconfirmed.
ASML’s Q2 revenue rose 11% and new-system shipments rose 28%, but missing bookings confirmation and weak price structure keep the cycle unresolved.
Morgan Stanley’s record quarter strengthens the operating case, while sector lag and an unresolved Wealth Management question raise the proof bar.
Morgan Stanley’s record returns strengthen the franchise case, but relative weakness and an unresolved control question keep the valuation contested.
July manufacturing activity accelerated sharply, strengthening cyclical rotation evidence while keeping rate sensitivity in focus.
Midday Market Check for Monday, August 3, 2026. Where the session stands: breadth, sectors, and what moved.
UnitedHealth improved Medicare cost evidence in July, but commercial pressure and a broader federal inquiry keep the repair incomplete.
UnitedHealth shows measurable Medicare cost improvement, while commercial pressure and a broader federal inquiry keep the repair incomplete.